Literature DB >> 10063859

Epithelial displacement after stereotactic 11-gauge directional vacuum-assisted breast biopsy.

L Liberman1, M Vuolo, D D Dershaw, E A Morris, A F Abramson, L R LaTrenta, N M Polini, P P Rosen.   

Abstract

OBJECTIVE: Displaced epithelial fragments at percutaneous biopsy of ductal carcinoma in situ (DCIS) may mimic stromal invasion. This study was undertaken to determine the frequency of epithelial displacement in DCIS lesions of patients who underwent stereotactic 11-gauge directional vacuum-assisted breast biopsy.
MATERIALS AND METHODS: We retrospectively reviewed 28 consecutive DCIS lesions in patients who underwent stereotactic 11-gauge directional vacuum-assisted breast biopsy followed by surgery. Surgical specimens were examined for histologic evidence of epithelial displacement, consisting of fragments of epithelium in artifactual spaces in breast parenchyma or in lymphovascular channels, accompanied by hemorrhage, fat necrosis, inflammation, hemosiderin-laden macrophages, or granulation tissue.
RESULTS: The median number of specimens obtained per lesion was 14 (range, seven to 45). The median interval from stereotactic biopsy to surgery was 27 days (range, 10-59 days). Surgery revealed DCIS in 19 (68%) of 28 lesions, DCIS and infiltrating carcinoma in four lesions (14%), and no residual carcinoma in five lesions (18%). Reactive changes at the biopsy site were identified in all cases. Displacement of benign epithelium into granulation tissue at the stereotactic biopsy site was identified in two cases (7%). We found no evidence of displacement of malignant epithelium.
CONCLUSION: Epithelial displacement is uncommon after stereotactic 11-gauge directional vacuum-assisted biopsy of the breast. We observed displacement of benign epithelium in two (7%) of 28 DCIS lesions and no displacement of malignant epithelium.

Entities:  

Mesh:

Year:  1999        PMID: 10063859     DOI: 10.2214/ajr.172.3.10063859

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  9 in total

Review 1.  Stereotactic and ultrasound-guided breast biopsy.

Authors:  T H Helbich; W Matzek; M H Fuchsjäger
Journal:  Eur Radiol       Date:  2003-11-13       Impact factor: 5.315

2.  Is Sentinel Lymph Node Dissection Warranted for Patients with a Diagnosis of Ductal Carcinoma In Situ?

Authors:  Ashleigh M Francis; Christine E Haugen; Lynn M Grimes; Jaime R Crow; Min Yi; Elizabeth A Mittendorf; Isabelle Bedrosian; Abigail S Caudle; Gildy V Babiera; Savitri Krishnamurthy; Henry M Kuerer; Kelly K Hunt
Journal:  Ann Surg Oncol       Date:  2015-04-24       Impact factor: 5.344

3.  Factors associated with upstaging of ductal carcinoma in situ diagnosed by core needle biopsy using imaging guidance.

Authors:  Cholatip Wiratkapun; Pachara Patanajareet; Bussanee Wibulpholprasert; Panuwat Lertsithichai
Journal:  Jpn J Radiol       Date:  2011-09-17       Impact factor: 2.374

4.  The current role of vacuum assisted breast biopsy system in breast disease.

Authors:  Hai-Lin Park; Lee Su Kim
Journal:  J Breast Cancer       Date:  2011-03-31       Impact factor: 3.588

Review 5.  Local control of ductal carcinoma in situ based on tumor and patient characteristics: the surgeon's perspective.

Authors:  Lisa A Newman
Journal:  J Natl Cancer Inst Monogr       Date:  2010

6.  Ultrasound-guided, vacuum-assisted excision in the diagnosis and treatment of clinically benign breast lesions.

Authors:  J Mathew; D J Crawford; M Lwin; C Barwick; A Gash
Journal:  Ann R Coll Surg Engl       Date:  2007-07       Impact factor: 1.891

Review 7.  Guidelines from the European Society of Breast Imaging for diagnostic interventional breast procedures.

Authors:  Matthew Wallis; Anne Tardivon; Anne Tarvidon; Thomas Helbich; Ingrid Schreer
Journal:  Eur Radiol       Date:  2007-02       Impact factor: 7.034

8.  Stereotactically guided breast biopsy: a review.

Authors:  Victoria Ames; Peter D Britton
Journal:  Insights Imaging       Date:  2011-01-20

Review 9.  Stereotactic breast biopsy: A review & applicability in the Indian context.

Authors:  Suma Chakrabarthi
Journal:  Indian J Med Res       Date:  2021-08       Impact factor: 5.274

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.